Scotiabank Issues Positive Forecast for Healthpeak Properties (NYSE:DOC) Stock Price

Healthpeak Properties (NYSE:DOC) had its price objective lifted by stock analysts at Scotiabank from $19.00 to $21.00 in a research report issued on Wednesday,Benzinga reports. The brokerage presently has a “sector perform” rating on the real estate investment trust’s stock. Scotiabank’s target price indicates a potential upside of 4.19% from the stock’s current price.

A number of other equities research analysts also recently commented on the company. Wall Street Zen raised Healthpeak Properties from a “sell” rating to a “hold” rating in a research report on Sunday, May 10th. Evercore downgraded Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 target price on the stock. in a research report on Monday, May 11th. Argus cut Healthpeak Properties from a “buy” rating to a “hold” rating in a report on Thursday, February 5th. Wells Fargo & Company reaffirmed a “positive” rating on shares of Healthpeak Properties in a research note on Tuesday, February 3rd. Finally, Royal Bank Of Canada increased their price objective on shares of Healthpeak Properties from $20.00 to $21.00 and gave the stock an “outperform” rating in a report on Thursday, May 14th. Five analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $19.23.

Healthpeak Properties Trading Up 0.6%

Shares of NYSE:DOC traded up $0.13 during trading on Wednesday, reaching $20.16. The stock had a trading volume of 617,638 shares, compared to its average volume of 8,920,160. The company has a quick ratio of 2.96, a current ratio of 2.96 and a debt-to-equity ratio of 1.15. The stock has a market cap of $13.90 billion, a P/E ratio of 62.88, a PEG ratio of 2.51 and a beta of 1.00. The business has a fifty day moving average price of $17.61 and a 200-day moving average price of $17.29. Healthpeak Properties has a fifty-two week low of $15.70 and a fifty-two week high of $20.27.

Healthpeak Properties (NYSE:DOC) last announced its earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.43 by $0.02. The firm had revenue of $752.95 million for the quarter, compared to analyst estimates of $694.59 million. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. Healthpeak Properties’s revenue was up 7.1% compared to the same quarter last year. During the same quarter last year, the business earned $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. As a group, analysts anticipate that Healthpeak Properties will post 1.75 earnings per share for the current fiscal year.

Insider Activity

In related news, insider Scott R. Bohn sold 10,989 shares of the stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total transaction of $213,736.05. Following the completion of the sale, the insider owned 7,636 shares of the company’s stock, valued at approximately $148,520.20. This represents a 59.00% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.23% of the company’s stock.

Institutional Investors Weigh In On Healthpeak Properties

Institutional investors have recently bought and sold shares of the business. Norges Bank acquired a new stake in shares of Healthpeak Properties in the fourth quarter worth $153,550,000. JPMorgan Chase & Co. lifted its holdings in shares of Healthpeak Properties by 41.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust’s stock valued at $540,730,000 after acquiring an additional 8,212,504 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in Healthpeak Properties by 694.6% during the 3rd quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust’s stock worth $153,520,000 after purchasing an additional 7,007,777 shares during the period. Bank of New York Mellon Corp boosted its position in Healthpeak Properties by 60.3% during the 1st quarter. Bank of New York Mellon Corp now owns 15,456,420 shares of the real estate investment trust’s stock worth $253,949,000 after purchasing an additional 5,815,189 shares during the period. Finally, Fuller & Thaler Asset Management Inc. increased its holdings in Healthpeak Properties by 19.2% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust’s stock valued at $476,744,000 after purchasing an additional 4,776,056 shares in the last quarter. 93.57% of the stock is currently owned by hedge funds and other institutional investors.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.